Search results for "Diabetes"
Diabetes, gabapentinoids, and high-value care
This issue covers some clinical dilemmas and offers insights into the value of care.
https://acphospitalist.acponline.org/archives/2019/12/letter-from-the-editor.htm
15 Dec 2019
Research on strokes and readmissions in COVID-19, updated guidance from NIH and SSC
One study showed that strokes were rare in COVID-19 patients, while another didn't find any connection between fever or biomarkers before discharge and readmissions. The NIH and the Surviving Sepsis Campaign (SSC) updated their COVID-19 critical care recommendations.
https://acphospitalist.acponline.org/weekly/archives/2021/02/10/1.htm
10 Feb 2021
September 2012
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2012/09/
Score predicts 90-day readmission risk after myocardial infarction
Predictive factors that could be identified before discharge included age, heart failure, heart rate, dialysis, diabetes, cerebrovascular disease, peripheral artery disease, and chronic lung disease.
https://acphospitalist.acponline.org/weekly/archives/2018/10/24/2.htm
24 Oct 2018
October 12, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/10/12/
May 25, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/05/25/
December issue online and in the mail
The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019
August 24, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/08/24/
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://acphospitalist.acponline.org/archives/2022/12/07/dapagliflozin-reduced-risk-for-hospitalization-in-ckd-patients-with-or-without-diabetes.htm
7 Dec 2022
Sodium bicarbonate and acetylcysteine did not reduce AKI after PCI in patients with CKD
A subgroup analysis of the PRESERVE trial compared sodium bicarbonate with sodium chloride and acetylcysteine with placebo in patients with stage III or IV chronic kidney disease (CKD) who underwent percutaneous coronary intervention (PCI).
https://acphospitalist.acponline.org/weekly/archives/2018/11/21/2.htm
21 Nov 2018